We tested whether the impairments in vivo is only translated into myotubes established from subjects with the highest degree of hyperandrogenism or hyperinsulinemia, and subdivided the PCOS group into low/high testosterone or low/high insulin and tested for differences in metabolic phenotype. The gene discussed is INS; the disease is polycystic ovary syndrome.